Key statistics
On Thursday, Karolinska Development AB (0P3C:LSE) closed at 1.22, 0.00% above its 52-week low of 1.22, set on Oct 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 1.22 |
Low | 1.22 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 267.52m |
Free float | 95.37m |
P/E (TTM) | -- |
Market cap | 312.47m SEK |
EPS (TTM) | -0.0209 SEK |
Data delayed at least 20 minutes, as of Oct 17 2024 17:47 BST.
More ▼
Announcements
- Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment
- Karolinska Developments portföljbolag BOOST Pharma har genomfört ett framgångsrikt FDA-möte och erhåller andra delen av tidigare avtalad investering
- Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine
- Karolinska Developments portföljbolag SVF Vaccines presenterar positiva data från en fas 1-studie med bolagets universella vaccin mot covid-19
- Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024
- Karolinska Developments portföljbolag Umecrine Cognition presenterar nya prekliniska Parkinsondata för golexanolon på den vetenskapliga konferensen INBC 2024
- Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
- Aktieägarna i Karolinska Development AB (publ) kallas till extra bolagsstämma
- Karolinska Development divests its holding in the Danish dermatology company Henlez
- Karolinska Development avyttrar hela innehavet i det danska dermatologibolaget Henlez
More ▼